Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    United Therapeutics Corpo...

    NASDAQ: UTHR · Real-Time Price · USD
    311.00
    -1.06 (-0.34%)
    At close: Aug 15, 2025, 1:04 PM

    United Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 2.88B 2.33B 1.94B 1.69B
    Cost of Revenue
    		 309.7M 257.5M 146.7M 122.5M
    Gross Profit
    		 2.57B 2.07B 1.79B 1.56B
    Operating Income
    		 1.38B 1.18B 979.7M 555.9M
    Interest Income
    		 199.1M 162.7M 45.2M 16.7M
    Pretax Income
    		 1.54B 1.27B 950.6M 593.9M
    Net Income
    		 1.2B 984.8M 727.3M 475.8M
    Selling & General & Admin
    		 638.6M 477.1M 487M 467M
    Research & Development
    		 481M 408M 322.9M 540.1M
    Other Expenses
    		 71.1M n/a n/a n/a
    Operating Expenses
    		 1.19B 885.1M 809.9M 1.01B
    Interest Expense
    		 42.9M 59.3M 32.4M 18.6M
    Selling & Marketing Expenses
    		 96.3M 81.8M 70.8M 64.4M
    Cost & Expenses
    		 1.5B 1.14B 956.6M 1.13B
    Income Tax Expense
    		 343.9M 289.5M 223.3M 118.1M
    Shares Outstanding (Basic)
    		 45.2M 46.8M 45.5M 44.9M
    Shares Outstanding (Diluted)
    		 48.5M 49.7M 48.5M 47.3M
    EPS (Basic)
    		 26.44 21.04 15.98 10.60
    EPS (Diluted)
    		 24.64 19.81 15.00 10.06
    EBITDA
    		 1.65B 1.39B 1.04B 736.8M
    EBIT
    		 1.58B 1.33B 989M 686.9M
    Depreciation & Amortization
    		 72.5M 53.2M 51.3M 49.9M

    Add to Watchlist